Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1956 Dec 15;75(12):980–993.

The L.E. (Lupus Erythematosus) Cell Reaction *

M A Ogryzlo
PMCID: PMC1823400  PMID: 13374645

Full text

PDF
980

Images in this article

983Fig. 1
on p.983
984Fig. 2
on p.984
984Fig. 3
on p.984
985Fig. 4
on p.985
986Fig. 5
on p.986
987Fig. 6
on p.987
988Fig. 7
on p.988

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES S. S., MOFFATT T. W., WEISS R. S. Demonstration of the LE cell in the absence of anticoagulant. J Invest Dermatol. 1950 Jun;14(6):397–400. doi: 10.1038/jid.1950.50. [DOI] [PubMed] [Google Scholar]
  2. BEERMAN H. The L.E. cell and phenomenon in lupus erythematosus. Am J Med Sci. 1951 Oct;222(4):473–481. doi: 10.1097/00000441-195110000-00016. [DOI] [PubMed] [Google Scholar]
  3. BERMAN L., AXELROD A. R., GOODMAN H. L., McCLAUGHRY R. I. So-called "lupus erythematosus inclusion phenomenon" of bone marrow and blood. Am J Clin Pathol. 1950 May;20(5):403–418. doi: 10.1093/ajcp/20.5.403. [DOI] [PubMed] [Google Scholar]
  4. BRIDGE R. G., FOLEY F. E. Placental transmission of the lupus erythematosus factor. Am J Med Sci. 1954 Jan;227(1):1–8. doi: 10.1097/00000441-195401000-00001. [DOI] [PubMed] [Google Scholar]
  5. BRUNSTING L. A., STICKNEY J. M., PEASE G. L., REED W. B. The clinical significance of the L.E. clot test. AMA Arch Derm. 1956 Apr;73(4):307–312. doi: 10.1001/archderm.1956.01550040001001. [DOI] [PubMed] [Google Scholar]
  6. CARRERA A. E., REID M. V., KURNICK N. B. Differences in susceptibility of polymorphonuclear leukocytes from several species to alteration by systemic lupus erythematosus Serum: application to a more sensitive L. E. phenomenon test. Blood. 1954 Dec;9(12):1165–1171. [PubMed] [Google Scholar]
  7. CHOMET B., KIRSHEN M. M., SCHAEFER G., MUDRIK P. The finding of the L. E. (Lupus Erythematosus) cells in smears of untreated, freshly drawn peripheral blood. Blood. 1953 Dec;8(12):1107–1109. [PubMed] [Google Scholar]
  8. DUBOIS E. L. The effect of the L. E. cell test on the clinical picture of systemic lupus erythematosus. Ann Intern Med. 1953 Jun;38(6):1265–1294. doi: 10.7326/0003-4819-38-6-1265. [DOI] [PubMed] [Google Scholar]
  9. DUSTAN H. P., TAYLOR R. D., CORCORAN A. C. Rheumatic and febrile syndrome during prolonged hydralazine treatment. J Am Med Assoc. 1954 Jan 2;154(1):23–29. doi: 10.1001/jama.1954.02940350025006. [DOI] [PubMed] [Google Scholar]
  10. EPPES W., LUDOVIC E. Demonstration of the "L.E." cell without use of anticoagulants. Blood. 1951 May;6(5):466–469. [PubMed] [Google Scholar]
  11. FINCH S. C., ROSS J. F., EBAUGH F. G., Jr Immunologic mechanisms of leukocyte abnormalities. J Lab Clin Med. 1953 Oct;42(4):555–569. [PubMed] [Google Scholar]
  12. GUEFT B. Depolymerization of nucleic acid in acute disseminated lupus erythematosus. Arch Derm Syphilol. 1950 Jun;61(6):892–897. doi: 10.1001/archderm.1950.01530130010003. [DOI] [PubMed] [Google Scholar]
  13. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  14. HASERICK J. R. Evaluation of three diagnostic procedures for systemic lupus erythematosus. Ann Intern Med. 1956 Mar;44(3):497–504. doi: 10.7326/0003-4819-44-3-497. [DOI] [PubMed] [Google Scholar]
  15. HASERICK J. R., LEWIS L. A. Blood factor in acute disseminated lupus erythematosus; induction of specific antibodies against L. E. factor. Blood. 1950 Aug;5(8):718–722. [PubMed] [Google Scholar]
  16. HASERICK J. R. Plasma L. E. test in systemic lupus erythematosus; study of 23 patients with positive L. E. tests. J Am Med Assoc. 1951 May 5;146(1):16–20. doi: 10.1001/jama.1951.03670010020005. [DOI] [PubMed] [Google Scholar]
  17. HELLER P., ZIMMERMAN H. J., ROZENGVAIG S., SINGER K. The L.E.-cell phenomenon in chronic hepatic disease. N Engl J Med. 1956 Jun 21;254(25):1160–1165. doi: 10.1056/NEJM195606212542503. [DOI] [PubMed] [Google Scholar]
  18. INDERBITZIN T. The experimental production of leukocytic changes in normal blood similar to LE-cells and morphologically identical with LE-cells. J Invest Dermatol. 1953 Feb;20(2):67–79. doi: 10.1038/jid.1953.11. [DOI] [PubMed] [Google Scholar]
  19. JOSKE R. A., KING W. E. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet. 1955 Sep 3;269(6888):477–480. doi: 10.1016/s0140-6736(55)93331-6. [DOI] [PubMed] [Google Scholar]
  20. KORTING G. W., SCHMITZ R. Induktion des Lupus-erythematodes-Zellphänomens mittels Urin. Dermatol Wochenschr. 1952;125(8):174–177. [PubMed] [Google Scholar]
  21. KURNICK N. B., PARISER S., SCHWARTZ L. I., LEE S. L., IRVINE W. Studies on desoxyribonuclease in systemic lupus erythematosus; non-participation of serum desoxyribonuclease in the L.E. phenomenon. J Clin Invest. 1952 Dec;31(12):1036–1041. doi: 10.1172/JCI102696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LEE S. L., MICHAEL S. R., VURAL I. L. The L.E. (lupus erythematosus) cell; clinical and chemical studies. Am J Med. 1951 Apr;10(4):446–451. doi: 10.1016/0002-9343(51)90289-6. [DOI] [PubMed] [Google Scholar]
  23. LEE S. L., SCHWARTZ L. I., PARISER S. Blood coagulation and the L. E. cell phenomenon. Blood. 1954 Oct;9(10):965–970. [PubMed] [Google Scholar]
  24. LINCOLN M., RICKER W. A. A case of periarteritis nodosa with L.E. cells; apparent complete remission with cortisone therapy. Ann Intern Med. 1954 Sep;41(3):639–646. doi: 10.7326/0003-4819-41-3-639. [DOI] [PubMed] [Google Scholar]
  25. MADDEN J. F. Comparison of muscle biopsies and bone marrow examinations in dermatomyositis and lupus erythematosus. Arch Derm Syphilol. 1950 Aug;62(2):192–205. doi: 10.1001/archderm.1950.01530150014002. [DOI] [PubMed] [Google Scholar]
  26. MANTER W. B. Late reaction to hydralazine (Apresoline) therapy. N Engl J Med. 1954 May 13;250(19):835–836. doi: 10.1056/NEJM195405132501908. [DOI] [PubMed] [Google Scholar]
  27. MATHIS H. B. A simple office procedure for demonstrating lupus erythematosus cells in peripheral blood. Blood. 1951 May;6(5):470–473. [PubMed] [Google Scholar]
  28. MOYER J. B., FISHER G. S. Experimental production of "L.E." cells. Am J Clin Pathol. 1950 Nov;20(11):1011–1015. doi: 10.1093/ajcp/20.11.1011. [DOI] [PubMed] [Google Scholar]
  29. PAULL A. M. Occurrence of the L.E. phenomenon in a patient with a severe penicillin reaction. N Engl J Med. 1955 Jan 27;252(4):128–129. doi: 10.1056/NEJM195501272520403. [DOI] [PubMed] [Google Scholar]
  30. PERRY H. M., Jr, SCHROEDER H. A. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc. 1954 Feb 20;154(8):670–673. doi: 10.1001/jama.1954.02940420032009. [DOI] [PubMed] [Google Scholar]
  31. REBUCK J. W., BERMAN L. Experimental production of the L. E. phenomenon in the skin of man. Proc Soc Exp Biol Med. 1950 Oct;75(1):259–264. doi: 10.3181/00379727-75-18165. [DOI] [PubMed] [Google Scholar]
  32. REINHARDT D. J., WALDRON J. M. Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1491–1492. doi: 10.1001/jama.1954.73690350001010. [DOI] [PubMed] [Google Scholar]
  33. ROHN R. J., BOND W. H. Some supravital observations on the L.E. phenomenon. Am J Med. 1952 Apr;12(4):422–432. doi: 10.1016/0002-9343(52)90223-4. [DOI] [PubMed] [Google Scholar]
  34. ROSS S. W., WELLS B. B. Systemic lupus erythematosus; a review of the literature. Am J Clin Pathol. 1952 Feb;23(2):139–160. doi: 10.1093/ajcp/23.2.139. [DOI] [PubMed] [Google Scholar]
  35. SCHULTZ I., BAUM J., ZIFF M. A new micro-method for the L.E. cell phenomenon. Proc Soc Exp Biol Med. 1955 Feb;88(2):300–302. doi: 10.3181/00379727-88-21569. [DOI] [PubMed] [Google Scholar]
  36. SEAMAN A. J., CHRISTERSON J. W. Demonstration of L.E. cells in pericardial fluid; report of a case. J Am Med Assoc. 1952 May 10;149(2):145–147. doi: 10.1001/jama.1952.72930190010009e. [DOI] [PubMed] [Google Scholar]
  37. SHACKMAN N. H., SWILLER A. I., MORRISON M. Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1492–1494. doi: 10.1001/jama.1954.73690350002010a. [DOI] [PubMed] [Google Scholar]
  38. SLOCUMB C. H. Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc Staff Meet Mayo Clin. 1953 Nov 18;28(23):655–657. [PubMed] [Google Scholar]
  39. SNAPPER I., NATHAN D. J. The mechanics of the L.E. cell phenomenon, studied with a simplified test. Blood. 1955 Jul;10(7):718–729. [PubMed] [Google Scholar]
  40. STICH M. H., FELDMAN F., MORRISON M. Pre-L. E. cell; a stage in development of the L. E. phenomenon. AMA Arch Derm Syphilol. 1952 May;65(5):581–586. doi: 10.1001/archderm.1952.01530240073009. [DOI] [PubMed] [Google Scholar]
  41. STICH M. H. The L. E. cell in the bone marrow in disseminated lupus erythematosus. N Y State J Med. 1950 Feb 15;50(4):433–illust. [PubMed] [Google Scholar]
  42. VOLPE R., HAUCH J. T. A case of scleroderma with L.E. cells and prolonged remission on cortisone therapy. Can Med Assoc J. 1955 Apr 15;72(8):597–599. [PMC free article] [PubMed] [Google Scholar]
  43. VOLPE R., OGRYZLO M. A. The cryoglobulin inclusion cell. Blood. 1955 May;10(5):493–496. [PubMed] [Google Scholar]
  44. WALSH J. R., EGAN R. L. The reliability of the L. E. test. N Engl J Med. 1952 May 15;246(20):775–776. doi: 10.1056/NEJM195205152462004. [DOI] [PubMed] [Google Scholar]
  45. WEISS R. S., SWIFT S. The significance of a positive L. E. phenomenon. AMA Arch Derm. 1955 Aug;72(2):103–112. doi: 10.1001/archderm.1955.03730320001001. [DOI] [PubMed] [Google Scholar]
  46. ZIMMER F. E., HARGRAVES M. M. The effect of blood coagulation on L.E. cell formation. Proc Staff Meet Mayo Clin. 1952 Oct 22;27(22):424–430. [PubMed] [Google Scholar]
  47. ZIMMERMAN H. J., WALSH J. R., HELLER P. Production of nucleophagocytosis by rabbit antileukocytic serum. Blood. 1953 Jul;8(7):651–654. [PubMed] [Google Scholar]
  48. van DOORMAAL T. A. J., SCHREUDER J. T. R. Uber die sogenannte Erythematodeszelle und deren Vorkommen in der Pleuroflüssigkeit bei einer an Lupus Erythematodes disseminatus acutus (subacutus) leidenden Patientin. Dermatologica. 1950;101(3):167–172. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES